Please assess the completion status of the following clinical trial:

Trial Title: Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients admitted to Grady Memorial Hospital who meet diagnosis criteria of DKA and who are willing to participate in the study protocol will be considered candidates for inclusion into the study.~* Diagnostic Criteria for DKA: Blood glucose \> 250 mg/dL, arterial or venous phenol hydroxylase (pH) \< 7.3, serum bicarbonate \< 18 milliequivalent/L, and moderate to severe ketonemia (acetoacetate ≥ 1:4 or βeta-hydroxybutyrate \> 3 mmol).~Exclusion Criteria:~* Hemodynamic instability (MAP \< 50 or patients requiring pressor)~* Significant identifiable medical or surgical illness, including but not limited to: acute myocardial infarction, congestive heart failure; respiratory failure requiring mechanical ventilation; acute or chronic renal insufficiency (serum creatinine \> 3.0 mg/dl); end stage liver failure, and cirrhosis.~* Patients with dementia or persistent altered mental status that would prevent collection of consent form and reliable information.~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Insulin glargine+glulisine (Type: EXPERIMENTAL): Daily insulin glargine + glulisine before meals
- Split-mixed NPH + Regular insulin (Type: ACTIVE_COMPARATOR): Split-mixed NPH + Regular insulin twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).